Polaris Uno: 43.5 Billion Won CB Voting Records Key to Control

For the Polaris Uno Deal, Procedure Matters More Than Price

In the control-transfer deal with Lumens Bios disclosed by Polaris Uno on the 21st, investors should focus first on the convertible bond issuance process rather than the transaction value. The 57.275 billion won deal reported by Infostock Daily is tied to a dispute over the legality of the convertible bonds intended to transfer control. This is why the transaction terms alone cannot be taken to mean that the control transfer has been completed.

In this case, Lumens Bios plans to convert the bonds into shares and combine them with existing shares to secure a 34% stake in Polaris Uno. The validity of the approval process at the time of issuance therefore concerns not merely a past disclosure but the ownership structure that will emerge.

From a 15 Billion Won Issuance to a Planned 43.5 Billion Won Sale

The assets being sold include 15 billion won in convertible bonds issued by Polaris Uno last December. The bonds are scheduled to be sold for 43.5 billion won. From an investment perspective, the focus should not be limited to the difference between the two amounts. The role of the securities in the control-transfer structure and the legality of the issuance resolution must also be verified.

Lumens Bios plans to convert the bonds into shares and combine them with existing shares to secure a 34% stake. What has been confirmed so far is the acquisition plan; the materials do not state whether the control-transfer transaction has been finalized. Investors should distinguish between a plan and a completed transaction.

Conflict Between Polaris Investment Partnership and Board Records

The annual report filed in March states that all seven directors at Polaris Uno’s board meeting on November 27 last year—including four inside directors, Choi Yong-seong, Cho Seong-woo, Ji Jun-gyeong, and Kim Young-gwan, and three outside directors—approved the convertible bond issuance. All four inside directors invested in Polaris Investment Partnership, the subscriber to the convertible bonds.

Cho Seong-woo invested 3 billion won, Ji Jun-gyeong 1.65 billion won, Choi Yong-seong 100 million won, and Kim Young-gwan 100 million won. The convertible bond issuance disclosure identified Polaris Investment Partnership as a related party. This creates a direct conflict between the official record of unanimous approval and whether the voting rights of interested directors were properly restricted.

Questions Left Unresolved by Polaris Group’s Explanation

A Polaris Group representative said the four interested inside directors were excluded from the vote, adding, “The annual report appears to contain an error.” If the company’s explanation is accurate, there is a discrepancy between the annual report and the actual vote. Conversely, if the annual report accurately reflects the vote, compliance with voting-right restrictions remains at issue.

The company did not respond to requests for voting records or other materials that could confirm the exclusion of the four inside directors. Based on currently available information, it is impossible to determine whether they were actually excluded from the vote, whether the board resolution violated the Commercial Act, or what legal effect the convertible bonds carry. Before legal interpretation, the central uncertainty lies in the records needed to establish the facts.

How the Issue Affects the Polaris Uno Investment Case

• Polaris Uno: Because the convertible bonds are the central instrument in the control transfer, controversy over the issuance process reduces the predictability of the transaction structure. If voting records confirm that the directors’ voting rights were excluded, the key facts underlying the procedural dispute would change.
• Lumens Bios: Its plan to secure a 34% stake assumes that the convertible bonds will be converted into shares and combined with existing shares. If it is conclusively determined that the bonds have a legal-validity problem, the acquisition plan could also be affected, but no such legal determination has yet been made.
• Polaris Investment Partnership: It is both the convertible bond subscriber and a related party identified in the disclosure. Because all four inside directors invested in the partnership, whether they actually participated in the issuance vote has become a direct subject of scrutiny.

Documents to Check in Upcoming Disclosures

• Check whether voting records are presented showing that the four inside directors were actually excluded from the vote.
• Watch for a correction addressing the discrepancy between the annual report’s record of unanimous approval and Polaris Group’s explanation.
• Distinguish whether any definitive ruling is issued on the legality and legal effect of the convertible bond issuance resolution.
• Confirm whether Lumens Bios ultimately secures the planned 34% stake in Polaris Uno and whether the control-transfer transaction is finalized.

Voting Evidence Will Determine the Control-Transfer Scenario

In the optimistic scenario, the company produces voting records proving that the four inside directors’ voting rights were excluded and resolves the discrepancy between its official filing and subsequent explanation. Even then, investors could not assume in advance that the control transfer has been completed, but at least the central facts in the current controversy would be established.

Downside risk would arise if supporting evidence remains unavailable or if a definitive determination finds a problem with the legal validity of the convertible bonds. This is also why one securities-industry official said, “The legality of the approval process must be thoroughly reviewed.” The starting point for the next assessment is not the transaction value but the voting record; until that record is disclosed, the 34% should be viewed as a planned stake, not an acquired one.

This article was automatically summarized and analyzed from the original news report. View Original Article (Infostock Daily)